Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1985 3
1986 3
1988 1
1993 1
1995 1
1999 1
2000 2
2001 6
2002 6
2003 5
2004 2
2005 6
2006 7
2007 4
2008 3
2009 5
2010 5
2011 6
2012 3
2013 15
2014 4
2015 3
2016 8
2017 11
2018 11
2019 5
2020 7
2021 7
2022 8
2023 5
2024 6
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Results by year

Filters applied: . Clear all
Page 1
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Reply.
Pertl L, Haas A, Hausberger S, Pichler T, Rabensteiner D, Seidel G, Malle EM, Weger M. Pertl L, et al. Among authors: weger m. Retina. 2018 Jun;38(6):e45. doi: 10.1097/IAE.0000000000002167. Retina. 2018. PMID: 29664822 No abstract available.
Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease.
Jouffe C, Weger BD, Martin E, Atger F, Weger M, Gobet C, Ramnath D, Charpagne A, Morin-Rivron D, Powell EE, Sweet MJ, Masoodi M, Uhlenhaut NH, Gachon F. Jouffe C, et al. Among authors: weger m. Proc Natl Acad Sci U S A. 2022 Mar 8;119(10):e2200083119. doi: 10.1073/pnas.2200083119. Epub 2022 Mar 1. Proc Natl Acad Sci U S A. 2022. PMID: 35238641 Free PMC article.
Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion: 72-Week Results from the BALATON and COMINO Trials.
Danzig CJ, Dinah C, Ghanchi F, Hattenbach LO, Khanani AM, Lai TYY, Shimura M, Abreu F, Arrisi P, Liu Y, Paris LP, Retiere AC, Willis JR, Schlottmann PG; BALATON and COMINO Investigators. Danzig CJ, et al. Ophthalmol Retina. 2025 Sep;9(9):848-859. doi: 10.1016/j.oret.2025.03.005. Epub 2025 Mar 17. Ophthalmol Retina. 2025. PMID: 40107501 Free article. Clinical Trial.
Stem cells and the circadian clock.
Weger M, Diotel N, Dorsemans AC, Dickmeis T, Weger BD. Weger M, et al. Dev Biol. 2017 Nov 15;431(2):111-123. doi: 10.1016/j.ydbio.2017.09.012. Epub 2017 Sep 9. Dev Biol. 2017. PMID: 28899666 Free article. Review.
Thrombophilic gene variants.
Steinbrugger I, Haas A, Maier R, Renner W, Mattes D, El-Shabrawi Y, Wedrich A, Schmut O, Weger M. Steinbrugger I, et al. Among authors: weger m. Ophthalmology. 2010 Apr;117(4):856-856.e1. doi: 10.1016/j.ophtha.2009.10.013. Ophthalmology. 2010. PMID: 20346836 No abstract available.
[Gaze-evoked amaurosis fugax].
Berglöff J, Mattes D, Brix-Grünwald G, Gröll R, Weger M. Berglöff J, et al. Among authors: weger m. Ophthalmologe. 2006 Dec;103(12):1044-6. doi: 10.1007/s00347-006-1385-9. Ophthalmologe. 2006. PMID: 16847649 German.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, Ohsawa S, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Jpn J Ophthalmol. 2023 May;67(3):264-279. doi: 10.1007/s10384-023-00979-8. Epub 2023 Mar 10. Jpn J Ophthalmol. 2023. PMID: 36897413 Free PMC article. Clinical Trial.
150 results